Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Neoplasm Metastasis 7Carcinoma, Non-Small-Cell Lung 6Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Skin Neoplasms 3Melanoma 3Head and Neck Neoplasms 3Breast Neoplasms 3Recurrence 2Prostatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Mycosis Fungoides 2Multiple Myeloma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Glioblastoma 2Colorectal Neoplasms 2Advanced Malignancies 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Stomach Neoplasms 1Recurrent Squamous Cell Carcinoma of Head 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Myelodysplastic Syndromes 1

Interventions

Magnetic Resonance Spectroscopy 5Iodine-131 3Fluorodeoxyglucose F18 3trametinib 2pazopanib 2belinostat 2Vemurafenib 2Trastuzumab 2Specimen Handling 2Sirolimus 2Paclitaxel 2Fluorouracil 2FAPI-46 2Docetaxel 2Cyclophosphamide 2Cisplatin 2Cetuximab 2Biopsy 2Bevacizumab 2Azacitidine 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1temsirolimus 1romidepsin 1pembrolizumab 1naporafenib 1mercaptoundecahydrododecaborate 1fludarabine phosphate 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Thyroid Neoplasms × cemiplimab × Clear all
NCT06902376 2025-11-05

NEO-COMBATXL

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
12 enrolled
EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡